Life Science Company News

Results 61 - 80 out of 500 displayed.
«  1  2  3 4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Certara Launches Next Generation CoAuthor™ Generative AI Regulatory Writing Software

Read more ››
By: GlobeNewswire - 17 Jun 2024

LUKE Acquires Coastal Clinical and Management Services to Expand Support of Government Agencies

Read more ››
By: GlobeNewswire - 17 Jun 2024

Enlivex Announces Positive Interim Data Readout from a Phase I/II Trial Evaluating Allocetra in End-Stage Knee Osteoarthritis

Read more ››
By: GlobeNewswire - 17 Jun 2024

Inhibikase Therapeutics Completes Enrollment of the Phase 2 ‘201’ Trial Evaluating Risvodetinib in Untreated Parkinson’s Disease

Read more ››
By: GlobeNewswire - 17 Jun 2024

Novo Nordisk A/S - share repurchase programme

Read more ››
By: GlobeNewswire - 17 Jun 2024

Prenetics Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program

Read more ››
By: GlobeNewswire - 17 Jun 2024

Goodness Growth Holdings Announces Closing of Recently Announced Non-Brokered Private Placement

Read more ››
By: GlobeNewswire - 17 Jun 2024

Microbot Medical Announces Brigham and Women's Hospital as a Site for its Pivotal Human Clinical Trial

Read more ››
By: GlobeNewswire - 17 Jun 2024

Kiniksa Pharmaceuticals Sponsors American Heart Association’s Addressing Recurrent Pericarditis Initiative

Read more ››
By: GlobeNewswire - 17 Jun 2024

Sharps Technology Ships First Orders for Securegard Disposable Smart Safety Syringes to Strategic Distribution Partner in Colombia

Read more ››
By: GlobeNewswire - 17 Jun 2024

Aprea Therapeutics Announces First Patient Dosed in ACESOT-1051 Phase 1 Trial Evaluating Oral WEE1 Inhibitor APR-1051

Read more ››
By: GlobeNewswire - 17 Jun 2024

FDA Approves Phase II Clinical Trial for Ruxoprubart in ANCA Associated Vasculitis (AAV) – a Chronic Rare Disease in Nephrology

Read more ››
By: GlobeNewswire - 17 Jun 2024

Evoke Pharma Reports Commercial Strategy Progress & Positive Momentum for GIMOTI

Read more ››
By: GlobeNewswire - 17 Jun 2024

Mustang Bio Announces Favorable Efficacy and Safety Data from Complete Waldenstrom Macroglobulinemia Cohort of Phase 1/2 Clinical Trial of MB-106, CD20-Targeted Autologous CAR-T Therapy

Read more ››
By: GlobeNewswire - 17 Jun 2024

Aerovate Therapeutics Announces 24-Week Topline Results from the Phase 2b Portion of IMPAHCT Evaluating AV-101 for the Treatment of Pulmonary Arterial Hypertension

Read more ››
By: GlobeNewswire - 17 Jun 2024

Rothamsted Research Grants Yield10 Bioscience an Exclusive, Global Commercial License to Advanced Technology for Producing Omega-3 Products in Camelina

Read more ››
By: GlobeNewswire - 17 Jun 2024

Longeveron Announces Exercise of Warrants for $4.4 Million Gross Proceeds

Read more ››
By: GlobeNewswire - 17 Jun 2024

Evaxion Publishes Data, Showing 67% Objective Response Rate in Metastatic Melanoma for the AI-Designed Personalized Cancer Vaccine EVX-01, in Leading Medical Journal

Read more ››
By: GlobeNewswire - 17 Jun 2024

Curium Continues to Make Strong Progress in European Roll-Out Of PYLCLARI® – 18F-PSMA PET Diagnostics of Patients With Prostate Cancer

Read more ››
By: GlobeNewswire - 17 Jun 2024

Shineco Enters into an Agreement with Turing Video to Jointly Develop Intelligent Health Care Products

Read more ››
By: GlobeNewswire - 17 Jun 2024
Results 61 - 80 out of 500 displayed.
«  1  2  3 4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate